Ukrainian Journal Health of Woman. 2025. 3(178): 96-102. doi: 10.15574/HW.2025.3(178).96102
Bondarenko N. P., Рrуlutska A. B., Kisilenko О. L., Martynova L. I.
Bogomolets National Medical University, Kyiv, Ukraine

For citation: Bondarenko NP, Рrуlutska AB, Kisilenko ОL, Martynova LI. (2025). Bone metabolism and osteoporosis in women during pregnancy and lactation – a modern view and treatment strategy. Ukrainian Journal Health of Woman. 3(178): 96-102. doi: 10.15574/HW.2025.3(178).96102
Article received: Apr 04, 2025. Accepted for publication: May 21, 2025.

Аim – to study and systematize the modern view on changes in mineral metabolism during pregnancy and lactation, their clinical impact, modern directions for the prevention and treatment of osteoporosis in women based on existing evidence on the impact of various therapeutic measures.
The relevance of the problem of osteoporosis during pregnancy and lactation is described. The etiopathogenetic factors that determine the occurrence of the disease are considered. Attention is focused on complications caused by osteoporosis during pregnancy and lactation. The effectiveness of methods of diagnosis and treatment of pregnant women with osteoporosis is analyzed.
Conclusions. Despite modern diagnostics and pharmacological means, the problem of osteoporosis during pregnancy and lactation (PLO) remains complex and in the future is the cause of a decrease in the quality of life of a woman. Given the lack of standard clinical recommendations for the treatment of PLO, to obtain effective treatment when choosing a drug, it is necessary to take into account many factors, starting from accurate diagnosis and ending with individual treatment. Cessation of breastfeeding and calcium with vitamin D monotherapy causes rapid bone recovery, prevents fractures and improves the quality of life of a woman in the future.
The authors declare no conflict of interest.
Keywords: osteoporosis, pregnancy, lactation, diagnostics, treatment, prevention.

REFERENCES

1. Anagnostis P, Lampropoulou-Adamidou K, Bosdou JK, Trovas G, Galanis P, Chronopoulos E et al. (2024, Feb 20). Comparative Effectiveness of Therapeutic Interventions in Pregnancy and Lactation-Associated Osteoporosis: A Systematic Review and Meta-analysis. J Clin Endocrinol Metab. 109(3): 879-901. https://doi.org/10.1210/clinem/dgad548; PMid:37708365 PMCid:PMC10876413

 2. Butscheidt S, Tsourdi E, Rolvien T, Delsmann A, Stürznickel J, Barvencik F et al. (2021, Jun). Relevant genetic variants are common in women with pregnancy and lactation-associated osteoporosis (PLO) and predispose to more severe clinical manifestations. Bone. 147: 115911. Epub 2021 Mar 12. https://doi.org/10.1016/j.bone.2021.115911; PMid:33716164

3. Calarge CA, Mills JA, Ziegler EE, Schlechte JA. (2018, Mar). Calcium and Vitamin D Supplementation in Boys with Risperidone-Induced Hyperprolactinemia: A Randomized, Placebo-Controlled Pilot Study. J Child Adolesc Psychopharmacol. 28(2): 145-150. Epub 2017 Nov 7. https://doi.org/10.1089/cap.2017.0104; PMid:29112461 PMCid:PMC5831755

4. Carsote M, Turturea MR, Valea A, Buescu C, Nistor C, Turturea IF. (2023, May 3). Bridging the Gap: Pregnancy-And Lactation-Associated Osteoporosis. Diagnostics (Basel). 13(9): 1615. https://doi.org/10.3390/diagnostics13091615; PMid:37175006 PMCid:PMC10177839

5. Fu Z, Ni X, Han S, Li M, Wang O, Xing X et al. (2025). Gene Variants and Bisphosphonates Treatment in Pregnancy and Lactation-Associated Osteoporosis (PLO): A Retrospective Study of 22 Chinese Patients. Calcif Tissue Int. 116(1): 70. https://doi.org/10.1007/s00223-025-01381-x; PMid:40327138

6. Grizzo FM, da Silva MJ, Pinheiro MM, Jorgetti V, Carvalho MD, Pelloso SM. (2015). Pregnancy and lactation-associated osteoporosis: bone Histomorphometric analysis and response to treatment with Zoledronic acid. Calcif Tissue Int. 97: 421-425. https://doi.org/10.1007/s00223-015-0028-z; PMid:26108650

7. Hartley A, Gregson CL, Paternoster L, Tobias JH. (2021, Apr). Osteoarthritis: Insights Offered by the Study of Bone Mass Genetics. Curr Osteoporos Rep. 19(2): 115-122. Epub 2021 Feb 4. https://doi.org/10.1007/s11914-021-00655-1; PMid:33538965 PMCid:PMC8016765

8. Kovacs CS, Ralston SH. (2015, Sep). Presentation and management of osteoporosis presenting in association with pregnancy or lactation. Osteoporos Int. 26(9): 2223-2241. Epub 2015 May 5. https://doi.org/10.1007/s00198-015-3149-3; PMid:25939309

9. LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, Saag KG et al. (2022, Oct). The clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 33(10): 2049-2102. Epub 2022 Apr 28.. Erratum in: Osteoporos Int. 2022 Jul 28; https://doi.org/10.1007/s00198-021-05900-y; PMid:35478046 PMCid:PMC9546973

10. Li D, Lu X, Gong Z, Zhu W, Xu G, Wu J et al. (2025, Jul 15). Magnetic Resonance Imaging-Based Vertebral Bone Quality Score as a Comprehensive Indicator to Evaluate the Trend of Bone Turnover Markers. Spine (Phila Pa 1976). 50(14): E278-E288. Epub 2025 Mar 28. https://doi.org/10.1097/BRS.0000000000005346; PMid:40152449

11. Li LJ, Zhang J, Gao P, Lv F, Song YW, Chang XY et al. (2018, Nov). Clinical characteristics and bisphosphonates treatment of rare pregnancy- and lactation-associated osteoporosis. Clin Rheumatol. 37(11): 3141-3150. Epub 2018 Jun 26. https://doi.org/10.1007/s10067-018-4185-0; PMid:29946989

12. Lou S, Lv H, Li Z, Tang P, Wang Y. (2018, Jan 23). Parathyroid hormone analogues for fracture healing: protocol for a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 8(1): e019291. https://doi.org/10.1136/bmjopen-2017-019291; PMid:29362267 PMCid:PMC5988099

13. Mäkinen VN, Sølling AS, McClung M, Langdahl BL. (2025, Mar). Romosozumab for the treatment of osteoporosis – a systematic review. J Endocrinol Invest. 48(3): 547-572. Epub 2024 Nov 2. https://doi.org/10.1007/s40618-024-02469-1; PMid:39487940

14. Meek JY, Noble L; Section on Breastfeeding. (2022, Jul 1). Policy Statement: Breastfeeding and the Use of Human Milk. Pediatrics. 150(1): e2022057988. https://doi.org/10.1542/peds.2022-057988; PMid:35921640

15. Misiorowski W. (2023). Pregnancy- and lactation-related osteoporosis: an important topic also for rheumatologists. Reumatologia. 61(4): 223-224. Epub 2023 Aug 31. https://doi.org/10.5114/reum/171597; PMid:37745142 PMCid:PMC10515126

16. Moon RJ, Green HD, D'Angelo S, Godfrey KM, Davies JH, Curtis EM et al. (2023, Jul). The effect of pregnancy vitamin D supplementation on offspring bone mineral density in childhood: a systematic review and meta-analysis. Osteoporos Int. 34(7): 1269-1279. Epub 2023 Apr 27. https://doi.org/10.1007/s00198-023-06751-5; PMid:37103591

17. Nordin BE, Roper A. (1955, Feb 26). Post-pregnancy osteoporosis; a syndrome? Lancet. 268(6861): 431-434. https://doi.org/10.1016/S0140-6736(55)90214-2; PMid:13234409

18. Pęczek K, Nowicki M. (2022). Effect of High-Dose Glucocorticoids on Markers of Inflammation and Bone Metabolism in Patients with Primary Glomerular Disease. Kidney Blood Press Res. 47(8): 534-544. Epub 2022 May 24. https://doi.org/10.1159/000524091; PMid:35609516

19. Qian Y, Wang L, Yu L, Huang W. (2021, Nov 3). Pregnancy- and lactation-associated osteoporosis with vertebral fractures: a systematic review. BMC Musculoskelet Disord. 22(1): 926. https://doi.org/10.1186/s12891-021-04776-7; PMid:34732196 PMCid:PMC8567545

20. Ralston SH. (2007, May). Genetics of osteoporosis. Proc Nutr Soc. 66(2): 158-165. https://doi.org/10.1017/S002966510700540X; PMid:17466098

21. Reid IR, Billington EO. (2022, Mar 12). Drug therapy for osteoporosis in older adults. Lancet. 399(10329): 1080-1092. https://doi.org/10.1016/S0140-6736(21)02646-5; PMid:35279261

22. Seely CR, McArt JAA. (2023, Dec). Circulating parathyroid hormone and serotonin in multiparous cows with differing postparturient serum calcium concentrations. J Dairy Sci. 106(12): 9587-9597. Epub 2023 Sep 9. https://doi.org/10.3168/jds.2022-23175; PMid:37690732

23. Stürznickel J, Butscheidt S, Amling M, Oheim R. (2023, Jun 21). Dynamics of Skeletal Status under Optimized Management during Subsequent Pregnancy in Three Women with a History of Pregnancy- and Lactation-Associated Osteoporosis Carrying pathogenic Variants in WNT1 and LRP5. JBMR Plus. 7(8): e10779. https://doi.org/10.1002/jbm4.10779; PMid:37614308 PMCid:PMC10443073

24. Taraktaş A, Ünlü Özkan F, İlleez ÖG, Geler Külcü D, Aktaş İ. (2018). Pregnancy-Associated Osteoporosis: Long-term Follow-up of a Patient with Two Pregnancies. Turk J Endocrinol Metab. 22: 50-53. https://doi.org/10.25179/tjem.2017-56508

25. Taylor CM, Perez-Barbosa L, Cardenas de la Garza JA, García-Hernández PA, Espinosa-Banuelos LG, Gutierrez-Leal LF et al. (2022, Feb 19). Bone metabolism and osteoporosis during pregnancy and lactation. Arch Osteoporos. 17(1): 36. https://doi.org/10.1007/s11657-022-01077-x; PMid:35182221

26. Valero C, Olmos JM, Humbert L, Castillo J, Hernández JL et al. (2021, Jun 2). 3D analysis of bone mineral density in a cohort: age- and sex-related differences. Arch Osteoporos. 16(1): 80. https://doi.org/10.1007/s11657-021-00921-w; PMid:34076788

27. Vestergaard P. (2020). Drugs Causing Bone Loss. Handb Exp Pharmacol. 262: 475-497. https://doi.org/10.1007/164_2019_340; PMid:31889220

28. Yazdani J, Khiavi RK, Ghavimi MA, Mortazavi A, Hagh EJ, Ahmadpour F. (2019, Nov-Dec). Calcitonin as an analgesic agent: review of mechanisms of action and clinical applications. Braz J Anesthesiol. 69(6): 594-604. Epub 2019 Dec 3. https://doi.org/10.1016/j.bjan.2019.08.004; PMid:31810524 PMCid:PMC9391842

29. Yordanov A, Vasileva-Slaveva M, Tsoneva E, Kostov S, Yanachkova V. (2025, Mar 18). Bone Health for Gynaecologists. Medicina (Kaunas). 61(3): 530. https://doi.org/10.3390/medicina61030530; PMid:40142340 PMCid:PMC11944197

30. Yun SJ, Sang H, Park SY, Chin SO. (2024, Jan 25). Effect of Hyperprolactinemia on Bone Metabolism: Focusing on Osteopenia/Osteoporosis. Int J Mol Sci. 25(3): 1474. https://doi.org/10.3390/ijms25031474; PMid:38338751 PMCid:PMC10855748